Skip to main content
2025 Summer Scientific Forum Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Shruti B. Patel, MS

Senior Scientist
Merck & Co., Inc.
Rahway, New Jersey

Shruti holds a Master's degree in Pharmacology, during which she conducted extensive research on the toxicology and pharmacological responses of Withania somnifera, a medicinal plant known for its potential anti-cancer properties, in collaboration with Pharmanza Pharmaceutical Company. Her research employed a variety of methodologies, including various assays, hematological evaluations, serum chemistry analyses, and histopathological assessments, to rigorously evaluate the safety and efficacy of the extract in small rodents.
Following the completion of her master’s program, Shruti joined Pfizer, where she focused on vaccine development and monoclonal antibodies (mAbs). In this role, she characterized multiple antibody-drug conjugates, employing advanced techniques such as chromatography and cell-based assays to support the development of innovative therapies.
Currently, Shruti is contributing her expertise at Merck, where she is engaged in the development of monoclonal antibodies. Her work involves conducting a series of stability studies to evaluate the integrity and shelf-life of these products, as well as developing residual assays and chromatography methods to ensure product quality and compliance with regulatory standards. Additionally, she plays a vital role in supporting the Biologics License Application (BLA) submission process, facilitating the advancement of new therapeutic options in the biopharmaceutical landscape.

Disclosure information not submitted.

Presentation(s):